These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 17594357)
1. Is hormone ablation still the right choice for advanced prostate cancer? Fitzpatrick JM BJU Int; 2007 Jul; 100 Suppl 2():36-9. PubMed ID: 17594357 [No Abstract] [Full Text] [Related]
2. Does the benefit justify the risk? Albertsen PC J Natl Cancer Inst; 2010 Jan; 102(1):4-5. PubMed ID: 19996059 [No Abstract] [Full Text] [Related]
3. The role of intermittent androgen deprivation in prostate cancer. Boccon-Gibod L; Hammerer P; Madersbacher S; Mottet N; Prayer-Galetti T; Tunn U BJU Int; 2007 Oct; 100(4):738-43. PubMed ID: 17662079 [No Abstract] [Full Text] [Related]
4. A review of the use of histrelin acetate in the treatment of prostate cancer. Crawford ED BJU Int; 2009 Mar; 103 Suppl 2():14-22. PubMed ID: 19228148 [No Abstract] [Full Text] [Related]
5. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms? Daskivich TJ; Oh WK Urology; 2006 May; 67(5):1084.e15-7. PubMed ID: 16698377 [TBL] [Abstract][Full Text] [Related]
10. [The effective therapy of the hot flashes during hormone withdrawal treatment in patients with advanced prostatic carcinoma]. Kliesch S; Behre HM; Roth S Dtsch Med Wochenschr; 1997 Jul; 122(30):940-5. PubMed ID: 9280708 [No Abstract] [Full Text] [Related]
11. [Quality of life of patients with locally-advanced prostate cancer as a criterium of therapeutic effectiveness]. Kaprin AD; Kostin AA; Tsybul'skiĭ AD Vopr Onkol; 2009; 55(3):285-90. PubMed ID: 19670727 [No Abstract] [Full Text] [Related]
13. [Hot flushes in men after surgical or pharmacologic castration]. Aubert J; Vigouroux V; Doré B Prog Urol; 1995 Sep; 5(4):507-9. PubMed ID: 7581499 [TBL] [Abstract][Full Text] [Related]
14. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate]. Berenguer Sánchez A Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304 [No Abstract] [Full Text] [Related]
15. Maximal androgen blockade for advanced prostate cancer. Klotz L Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):331-40. PubMed ID: 18471790 [TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate. Spetz AC; Hammar M; Lindberg B; Spångberg A; Varenhorst E; J Urol; 2001 Aug; 166(2):517-20. PubMed ID: 11458057 [TBL] [Abstract][Full Text] [Related]
17. [Hormone therapy in advanced and generalized carcinoma of the prostate]. Vachalovský V; Dvorácek J; Voboril V Cas Lek Cesk; 1998 Aug; 137(17):532-6. PubMed ID: 9787507 [TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation increases the risk of fracture in prostate cancer patients: a population-based study in Chinese patients. Wu CT; Yang YH; Chen PC; Chen MF; Chen WC Osteoporos Int; 2015 Sep; 26(9):2281-90. PubMed ID: 25990353 [TBL] [Abstract][Full Text] [Related]